Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Staging models applied in a sample of patients with bipolar disorder: Results from a retrospective cohort study.

Journal of affective disorders·2022
Same author

Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2022
Same author

Childhood trauma and treatment outcomes during mood-stabilising treatment with lithium or quetiapine among outpatients with bipolar disorder.

Acta psychiatrica Scandinavica·2022
Same author

Lithium plus antipsychotics or anticonvulsants for bipolar disorder: Comparing clinical response and metabolic changes.

The Australian and New Zealand journal of psychiatry·2022
Same author

Cardiometabolic risk markers during mood-stabilizing treatment: Correlation with drug-specific effects, depressive symptoms and treatment response.

Journal of affective disorders·2021
Same author

Response and remission rates during 24 weeks of mood-stabilizing treatment for bipolar depression depending on early non-response.

Psychiatry research·2021

Related Experiment Videos

Combination therapy versus monotherapy in bipolar disorder.

Terence A Ketter1

  • 1Department of Psychiatry and Behavior Sciences and Bipolar Disorders Clinic, Stanford University School of Medicine, Stanford, Calif., USA.

The Journal of Clinical Psychiatry
|February 11, 2009
PubMed
Summary

For bipolar disorder patients with breakthrough manic or mixed episodes, optimize first-line medication dosage. If needed, combine atypical antipsychotics with mood stabilizers, considering individual patient factors for effective treatment.

Related Experiment Videos

Area of Science:

  • Psychiatry
  • Pharmacology
  • Clinical Psychology

Background:

  • Bipolar disorder requires ongoing maintenance therapy.
  • Breakthrough manic or mixed episodes can occur despite treatment.
  • Optimal dosing of first-line medications is crucial.

Observation:

  • Patients may experience manic or mixed episodes during maintenance therapy.
  • Assessing current medication dosage is the initial step.
  • Further interventions may be necessary if episodes persist.

Findings:

  • Combining atypical antipsychotics with mood stabilizers is a viable treatment option.
  • Treatment decisions should prioritize medication efficacy, tolerability, and safety for each patient.
  • Psychosocial therapy can be an effective adjunct to pharmacotherapy.

Implications:

  • Personalized treatment strategies are essential for managing bipolar disorder.
  • Combination therapy may offer improved outcomes for refractory episodes.
  • Integrating psychosocial interventions can enhance relapse prevention in bipolar disorder.